Results for tag: "Genvoya"

Genvoya is a brand of antiretroviral medication used to treat HIV/AIDS. It is a combination of four drugs: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Genvoya is a once-daily, single-tablet regimen that helps to reduce the amount of HIV in the body and prevent further damage to the immune system. It is designed to be taken with or without food and is suitable for adults and adolescents over 12 years of age. Genvoya is a part of the larger HIV/AIDS drug market, which includes a variety of medications used to treat the virus. These drugs are used to reduce the amount of virus in the body, prevent the virus from replicating, and reduce the risk of HIV-related illnesses. The Genvoya market includes a number of pharmaceutical companies, such as Gilead Sciences, Merck, and Bristol-Myers Squibb. These companies produce and distribute the drug, as well as provide support and education to patients and healthcare providers. Other companies in the market include ViiV Healthcare, Janssen, and Mylan. These companies provide additional HIV/AIDS medications, as well as support services for patients and healthcare providers. Show Less Read more